Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sakar Healthcare Limited (NSE: SAKAR), ISIN INE732S01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SAKAR last traded at ₹1027.85 (+5.36%), with a 52-week range of ₹352.50 to ₹1229.85 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 51.70%, FIIs 12.34%, DIIs 11.92%, mutual funds 0.00%.
EquiSense Score (ECS): 79/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.